Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma

Summary Background: Dexamethasone, cytarabine (ara-C), and cisplatin (DHAP) can be used effectively to treat patients with non-Hodgkin's lymphoma (NHL). We hypothesized that substitution of cisplatin by oxaliplatin (L-OHP) could result in less toxicity and greater efficacy. L-OHP is active in p...

Full description

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 12; no. 10; pp. 1439 - 1443
Main Authors: Machover, D., Delmas-Marsalet, B., Misra, S.C., Gumus, Y., Goldschmidt, E., Schilf, A., Frénoy, N., Emile, J.-F., Debuire, B., Guettier, C., Farrokhi, P., Boulefdaoui, B., Norol, F., Parquet, N., Ulusakarya, A., Jasmin, C.
Format: Journal Article
Language:English
Published: Oxford Oxford University Press 01-10-2001
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first